Explore

Companies

Drugs

/

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Other/Randomized Controlled Trial

Randomized Controlled Trial

26

Pipeline Programs↗

40

Active Trials↗

12

Companies Involved↗

Randomized Controlled Trial is an emerging landscape with 26 programs across 12 companies. 10 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

58/100

Pipeline Velocity

36/100

Mech. Concentration

22/100

Completion Rate

84/100

Attrition Rate

10/100

Pipeline

Programs by Phase

Preclinical12

PERT at Discharge

Sunnybrook Health Sciences Centre

Plasma Exchange

Sanofi

Faecal Tagging

University of Roma La Sapienza

Bowel Cleansing

University of Roma La Sapienza

Measles Vaccine

GSK

Phase 11

Cannabidiol

Jazz Pharmaceuticals

Phase 23

Vonoprazan

Phathom Pharmaceuticals, Inc.

Spironolactone

Pfizer

Ondansetron

Novartis

Phase 310

Lidocaine

MEDRx USA, Inc.

Antibiotic

Pfizer

Suxiao Jiuxin Pill

Peking University First Hospital

Botulinum Toxin

Meshalkin Research Institute of Pathology of Circulation

Bupropion-Naltrexone-Metformin

WW International Inc

Approved

No programs

Analysis

Modality Breakdown

96%

Small molecule

23 of 24 classified programs — the dominant modality here.

Small molecule leads; the ring shows all 24 classified programs, each share of the total. Modality classified for 100% of 26 pipeline programs.

Analysis

Trial Status

206

clinical trials

Completed109 · 53%

Unknown status37 · 18%

Not yet recruiting18 · 9%

Terminated14 · 7%

Active, not recruiting11 · 5%

Recruiting10 · 5%

Other7 · 3%

Clinical Trials

Trial Activity

206 trials

A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients

Recruiting·UUniversity of California, Irvine·N/A·NCT03977207·336 enrolled

Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial

Recruiting·—·Phase 3·NCT05040464·166 enrolled

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial

Recruiting·—·Phase 4·NCT05899140·100 enrolled

Ondansetron As a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial

Recruiting·EEmory University·Phase 2·NCT05378113·120 enrolled

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

Recruiting·NNational Taiwan University Hospital·N/A·NCT06966778·135 enrolled

Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial

Recruiting·NNanjing First Hospital, Nanjing Medical University·Phase 4·NCT07349875·3,826 enrolled

XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)

Recruiting·GGuangzhou University of Traditional Chinese Medicine·N/A·NCT06055179·98 enrolled

Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial

Recruiting·KKing Edward Medical University·Phase 2·NCT07267260·154 enrolled

Minoxidil for Treating White Hair: A Randomized Controlled Trial

Recruiting·SSouthern Medical University, China·Phase 4·NCT06813963·100 enrolled

The Analgesic Efficacy of Perineural Nalbuphine as an Adjuvant to Bupivacaine in Ultrasound Guided Superficial Cervical Plexus Nerve Block for Thyroid Surgeries. A Double Blinded Randomized Controlled Trial.

Recruiting·—·Phase 2·NCT06633068·54 enrolled

A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)

Active, not recruiting·WWW International Inc·Phase 4·NCT06605703·226 enrolled

A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD

Active, not recruiting·SSan Francisco Veterans Affairs Medical Center·Phase 2·NCT03339258·80 enrolled

Cervical Ripening With Misoprostol vs Isosorbide Mononitrate ; A Parallel -Arm Randomized Controlled Trial

Active, not recruiting·—·N/A·NCT07121634·80 enrolled

Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque

Active, not recruiting·SSamsung Medical Center·Phase 4·NCT03169985·280 enrolled

Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial

Active, not recruiting·CCoordinación de Investigación en Salud, Mexico·Phase 4·NCT07248761·76 enrolled

Page 1 of 14

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)